Reason: HCV cirrhosis, HCC s/p TACE/RFA 7/2016: follow up imaging for treatment effect. ABDOMEN:LIVER, BILIARY TRACT: Cirrhotic liver morphology including left hepatic lobe and caudate lobe hypertrophy as well as fissural prominence.In hepatic segment 5 at the site of the previously seen focal lesion compatible with HCC, there is a new ablation cavity which measures 1.7 x 3.7 cm and demonstrates some intrinsic T1 hyperintensity compatible with blood products. There is no definite associated marginal or nodular arterial enhancement with washout to suggest residual disease or recurrence. There is a new area of arterial enhancement in segment 5/6 (series 9, image 31) which measures 0.9 x 1.3 cm and lacks washout on more delayed images. This is nonspecific but may reflect a transient hepatic intensity difference. Status post cholecystectomy with prominence of the common bile duct up to 11 mm, not significantly changed. No evidence of choledocholithiasis.SPLEEN: No significant abnormality noted.PANCREAS: No significant abnormality noted.ADRENAL GLANDS: No significant abnormality noted.KIDNEYS, URETERS: No significant abnormality noted.RETROPERITONEUM, LYMPH NODES: No significant abnormality noted.BOWEL, MESENTERY: No significant abnormality noted.BONES, SOFT TISSUES: No significant abnormality noted.OTHER: No significant abnormality noted.
1.Cirrhotic liver morphology. 2.Interval ablation of segment 5 lesion without specific evidence of marginal residual disease or recurrence.3.New small area of arterial enhancement in segment 5/6 without washout which is favored to represent a transient hepatic intensity difference but should be followed on subsequent examinations.